Barely Significant
← all excerpts

Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia.

CNS Drugs · 2022 · PMC9345797 · PMID 35831706

Europe PMCDOI
1
hedged sentence
0.0740
closest p · 1.5× alpha
0.0740
boldest claim

The sentences

a nonsignificant trendp = 0.074so close (0.05 < p ≤ 0.1)
The results regarding the cognitive measures state a nonsignificant trend-like group difference in the mixed-model analysis ( p = 0.074).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.